Grey and white matter differences in Chronic Fatigue Syndrome : A voxel-based morphometry study by Finkelmeyer, Andreas et al.
Contents lists available at ScienceDirect
NeuroImage: Clinical
journal homepage: www.elsevier.com/locate/ynicl
Grey and white matter diﬀerences in Chronic Fatigue Syndrome – A voxel-
based morphometry study
Andreas Finkelmeyera,⁎, Jiabao Heb, Laura Maclachlanc, Stuart Watsona, Peter Gallaghera,
Julia L. Newtond, Andrew M. Blamiree
a Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, England, UK
b Aberdeen Biomedical Imaging Centre, University of Aberdeen, Scotland, UK
c Department of Public Health and Community Medicine, Göteborgs Universitet, Göteborg, Sweden
d Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, England, UK
e Newcastle Magnetic Resonance Centre, Newcastle University, Newcastle upon Tyne, England, UK
A R T I C L E I N F O
Keywords:
Chronic Fatigue Syndrome
Voxel-based morphometry
Insula
Amygdala
Midbrain
A B S T R A C T
Objective: Investigate global and regional grey and white matter volumes in patients with Chronic Fatigue
Syndrome (CFS) using magnetic resonance imaging (MRI) and recent voxel-based morphometry (VBM) methods.
Methods: Forty-two patients with CFS and thirty healthy volunteers were scanned on a 3-Tesla MRI scanner.
Anatomical MRI scans were segmented, normalized and submitted to a VBM analysis using randomisation
methods. Group diﬀerences were identiﬁed in overall segment volumes and voxel-wise in spatially normalized
grey matter (GM) and white matter (WM) segments.
Results: Accounting for total intracranial volume, patients had larger GM volume and lower WM volume. The
voxel-wise analysis showed increased GM volume in several structures including the amygdala and insula in the
patient group. Reductions in WM volume in the patient group were seen primarily in the midbrain, pons and
right temporal lobe.
Conclusion: Elevated GM volume in CFS is seen in areas related to processing of interoceptive signals and stress.
Reduced WM volume in the patient group partially supports earlier ﬁndings of WM abnormalities in regions of
the midbrain and brainstem.
1. Introduction
Chronic Fatigue Syndrome (CFS) is a chronic condition of unclear
aetiology that is characterised by a variety of diverse symptoms such as
chronic, disabling fatigue, unrefreshing sleep, post-exertional malaise,
muscle pains and reduced cognitive performance. Brain imaging studies
in CFS suggest alterations in brain structure and function in at least
subgroups of CFS patients (Natelson, 2013). Previous studies on volu-
metric brain diﬀerences in CFS are scarce and have produced incon-
sistent ﬁndings. An early voxel-based morphometry (VBM) study re-
ported reduction of grey matter (GM) volume in bilateral prefrontal
cortex which correlated with reduced functional status (Okada et al.,
2004). In contrast, a more recent VBM study showed regional reduc-
tions in GM volume only in occipital and parahippocampal regions, as
well as white matter (WM) volume reductions in occipital regions (Puri
et al., 2012). An overall reduction in supratentorial WM volume has
been reported, with no diﬀerence in cortical GM volume (Zeineh et al.,
2015). Overall reductions in GM volume have been reported in two
independent cohorts of CFS patients (de Lange et al., 2005), but this
was not replicated in a subsequent study by the same group (van der
Schaaf et al., 2016) or in recent studies by another group (Barnden
et al., 2011; Barnden et al., 2016). These studies also found no sig-
niﬁcant regional GM or WM volume diﬀerences between CFS patients
and controls. Instead, signiﬁcant diﬀerences were found in the asso-
ciations of brain MRI measures (regional volume, scaled image in-
tensity) and various cardiovascular parameters (heart rate, blood
pressures) between CFS patients and controls, which were largely
conﬁned to regions of predominant WM, and with several consistent
and strong ﬁndings in the brainstem (Barnden et al., 2011; Barnden
et al., 2016).
Various factors may have contributed to these disparate ﬁndings in
the literature. They include the size and make-up of the samples as well
as diﬀerences in imaging and analysis methodology. Apart from the
most recent study (van der Schaaf et al., 2016), patient sample sizes of
all previous studies are small to moderate with< 30 patients in all
studies. Furthermore, not all studies explicitly excluded patients with a
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psychiatric comorbidity, which may have aﬀected ﬁndings. Diﬀerences
in analysis methodology included the identity and version of the pro-
cessing software, diﬀerent choices of the size of the smoothing kernel
and the selection of covariates for the statistical model. For instance,
several previous studies have included segment volume (as opposed to
total intracranial volume) as covariate in their models. This may have
reduced the power to detect local diﬀerences as such local diﬀerences
would have also inﬂuenced the overall segment volume, and thus sys-
tematic diﬀerences in local volume could be falsely attributed to the
segment volume covariate (Henley et al., 2010).
Given the heterogeneity of previous ﬁndings, the current study in-
vestigated GM and WM volume diﬀerences between CFS patients and
healthy controls with a moderately sized sample of CFS patients which
has been meticulously screened for psychiatric comorbidities. The VBM
analysis of the present study will rely on a recent implementation of the
segmentation and normalization procedures (Gaser and Dahnke, 2016),
which incorporates several major changes in the image processing al-
gorithms that are aimed to improve the quality of the resulting nor-
malized tissue segments over previous implementations.
2. Methods
2.1. Patients
A group of 42 patients with CFS (32 female, mean age 45.2) parti-
cipated in this study as part of a larger project investigating the role of
autonomic dysfunctions in CFS. They were recruited via the Newcastle
and North Tyneside National Health Service (NHS) Clinical CFS Service.
Consecutive patients attending the clinic were provided with a Patient
Information Sheet and invited to contact the research team if they were
willing to be involved. Participants were not selected according to any
criteria other than fulﬁlling the Fukuda diagnostic criteria of CFS
(Fukuda et al., 1994). During an initial screening visit using the
Structured Clinical Interview for the Diagnostic and Statistical Manual
for Mental Disorders (version IV; SCID-IV, (First et al., 2002)) patients
that screened positive for a current or past major depressive episode
were excluded from further participation in the study. None of the
participants that were scanned fulﬁlled diagnostic criteria for any other
axis-I disorder.
A group of 30 healthy volunteers were recruited via notices pro-
vided in the hospital and University together with a distribution of
posters via the local patient support groups. One third were recruited as
part of the above mentioned CFS study, with the remaining two thirds
being recruited as healthy volunteers in a clinical trial investigating
treatment-resistant major depression (McAllister-Williams et al., 2016).
Recruitment for both studies happened during approximately the same
time period. Both studies had similar requirements in terms of the age
and sex distribution of the healthy volunteer groups, and enforced the
same set of relevant inclusion and exclusion criteria for healthy vo-
lunteers, i.e. absence of any psychiatric or major physical health con-
ditions.
All participants provided written informed consent. The study was
conducted in accordance with the Declaration of Helsinki. The study
received a favourable ethical opinion from the local NHS Research
Ethics Committee.
2.2. MR imaging and processing
All participants were scanned on the same 3T Achieva® (Philips
Healthcare, Best, NL) MR scanner with an 8 channel head coil for signal
detection at the Newcastle Magnetic Resonance Centre. A standard
clinical T1-weighted anatomical scan was collected using a 3D
MPRAGE sequence (TE = 4.6 ms, TR = 8.3 ms, ﬂip angle = 8°, 3D-
acquisition, FOV: 240 mm (AP) × 216 mm (FH) × 180 mm (LR), 1 mm
isotropic voxel size). Images were manually reoriented to place their
native-space origin at the anterior commissure. Images were then pre-
processed using the Computational Anatomy Toolbox (CAT12) (Gaser
and Dahnke, 2016) for SPM12 (www.ﬁl.ac.uk/spm/) in Matlab R2014b
(The Mathworks, Inc., Natick, MA, USA). This included bias-ﬁeld and
noise removal, skull stripping, segmentation into grey and white
matter, and ﬁnally normalization to MNI space using DARTEL to a
1.5 mm isotropic adult template provided by the CAT12 toolbox. Some
parameters of these steps were slightly adjusted from their default va-
lues, as initial segmentations had occasionally resulted in mis-
classiﬁcation of the meninges and transverse sinus as grey matter. In-
tensity modulation of the normalized tissue segments accounted for
both global aﬃne transformations and local warping. The toolbox
further provided ratings of image data quality, which were used to
identify problems with individual images. These assess basic image
properties, noise and geometric distortions (e.g. due to motion) and
combine them into a weighted image quality rating (IQR). As a result
the scan of one control participant was excluded from further analysis
as it had an IQR above 2.7, which was> 5 standard deviations above
the mean rating of the sample (1.986 ± 0.133). A further check of
sample homogeneity indicated large discrepancies between the overall
sample and one (additional) control participant, who was subsequently
removed, leaving 28 of 30 healthy control participants for ﬁnal ana-
lysis. Grey and white matter segments were then spatially smoothed
using a 6 mm FWHM Gaussian smoothing kernel.
2.3. Statistical analysis
Overall volumes of GM, WM, CSF and their sum (total intracranial
volume; TIV), as estimated by the CAT12 toolbox, were compared using
independent sample t-tests in SPSS version 21 (IBM Corp., Armonk, NY,
USA). Exploratory analyses in the patient group related segment vo-
lume and TIV to several illness characteristics using simple and multiple
regression analyses: total and subscale scores of the Fatigue Impact
Scale (FIS) (Fisk et al., 1994), total score on the Cognitive Failures
Questionnaire (CFQ) (Broadbent et al., 1982), total score on the 31-
item version of the Composite Autonomic Symptom Scale (COMPASS-
31) (Sletten et al., 2012), self-reported age at onset and derived dura-
tion of symptoms.
Voxel-based group comparisons of smoothed GM and WM segments
were performed using permutation tests using the randomise command
(Winkler et al., 2014) of the FMRIB Software Library (Jenkinson et al.,
2012) with the threshold-free cluster enhancement (TFCE) option
(Smith and Nichols, 2009). This approach has been shown to be an
eﬀective method to deal with smoothness nonstationarity in VBM
analyses (Salimi-Khorshidi et al., 2011) and its eﬀects on cluster-based
inference (Eklund et al., 2016). Tests included age, sex and total in-
tracranial volumes as confound regressors. The number of permutations
was set to 10,000. The TFCE method with randomisation testing pro-
duces maps of cluster-enhanced t statistics (pseudo-t) and maps of p-
values that correct for multiple comparisons (across space) (Smith and
Nichols, 2009). Voxels were considered to be signiﬁcantly diﬀerent
between groups when their value on these maps was p < 0.05.
3. Results
Table 1 shows basic participant characteristics and overall brain
segment volume measures. There were no diﬀerences between the
groups in terms of age (patients: M = 45.6, SD = 11.7; controls:
M = 48.4, SD = 11.3, t(68) = 0.984, p = 0.329) or gender (patients:
32f/10 m; controls: 19f/9 m, χ2 = 0.590, p = 0.442). Controls showed
slightly larger total intracranial volume (TIV) than patients (patients:
M = 1486.5 ml, SD = 129.6; controls: M = 1559.5 ml, SD = 148.4; t
(68) = 2.179, p = 0.033). This diﬀerence was driven by a diﬀerence in
overall WM volume (patients: M = 516.5 ml, SD = 57.6; controls:
M = 558.7 ml, SD = 57.6; t(68) = 3.007, p = 0.004). There was also a
trend for larger volume of cerebrospinal ﬂuid (CSF) in controls (pa-
tients: M = 303.4 ml, SD = 61.4; controls: M = 332.2 ml, SD = 76.1; t
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(68) = 1.744, p = 0.086). Absolute GM volumes did not diﬀer between
the CFS group (M = 666.5 ml, SD = 57.8) and the control group
(M = 668.6 ml, SD = 60.5; t(68) = 0.140, p = 0.889). Given the
group diﬀerence in TIV, the analysis of GM, WM and CSF volumes were
repeated using Analysis of Covariance (ANCOVA) while covarying for
TIV. Patients had higher adjusted GM volume (Madj = 675.7 ml) than
controls (Madj = 654.8 ml; F(1,67) = 4.144, p = 0.046), and lower
adjusted WM volume (CFS: Madj = 527.2 ml; HC: Madj = 542.7 ml; F
(1,67) = 4.717, p = 0.033). There was no signiﬁcant diﬀerence in
adjusted CSF volume (p = 0.696).
The VBM analysis showed signiﬁcant diﬀerences in GM volume in
several regions throughout the brain (see Fig. 1, Table 2). Patients
showed higher GM in widespread areas of the right temporal lobe in-
cluding the insular cortex, in various subcortical areas such as the bi-
lateral amygdala, putamen, thalamus and hippocampus, parts of the left
inferior frontal lobe and left occipital lobe. There were no signiﬁcant
areas with reduced GM volume in the patient group.
Signiﬁcant voxel-wise diﬀerences were also seen in a number of
white matter regions (see Fig. 2, Table 3). Patients showed reduced WM
compared to controls in bilateral areas of the internal and external
capsule and anterior midbrain, extending caudally into the bilateral
pons, dorsally into the right prefrontal lobe and anteriorly into inferior
frontal lobe WM. Additional areas of reduced WM were seen in anterior
parts of the right temporal lobe. No areas showed increased WM in the
CFS group compared to the control group.
3.1. Relationship to clinical characteristics
Table 4 shows the results of simple (TIV) and multiple regression
(GM, WM, CSF volumes) analyses when predicting clinical character-
istics based on volumes. These show negative associations between TIV
and almost all questionnaire measures of symptom severity. The mul-
tiple regression shows these negative associations for GM and CSF vo-
lumes, but not WM volume.
4. Discussion
The present study investigated whole-brain and voxel-wise grey
matter and white matter volume diﬀerences between patients with CFS
and healthy controls. Compared to previous studies of volumetric dif-
ferences (Barnden et al., 2011; Barnden et al., 2016; de Lange et al.,
2005; Okada et al., 2004; Puri et al., 2012), with n = 42 the current
study investigated one of the largest CFS patient samples to date. Only
the recent study by van der Schaaf and colleagues reported ﬁndings
from a larger sample of CFS patients (van der Schaaf et al., 2016).
However, this study focused almost exclusively on GM.
Whole-brain volume diﬀerences were seen in white matter with
patients showing reduced WM volumes, after accounting for the dif-
ference in TIV. We therefore do not replicate the ﬁndings of de Lange
and colleagues (de Lange et al., 2005) who reported reduced GM
Table 1
Group demographics and overall segment volumes.
ME/CFS Control Test statistic p-Value
Age (years) 45.6 (11.7) 48.4 (11.3) t= 0.984 0.33
Gender 32f/10m 19f/9m χ2 = 0.590 0.44
TIV (ml) 1486.5
(129.6)
1559.5
(148.4)
t= 2.179 0.033
GM volume (ml)
Absolute (M, SD) 666.5 (57.8) 668.6 (60.5) t= 0.140 0.889
TIV-adjusted (M,
SE)
675.7 (6.35) 654.8 (7.83) F = 4.144 0.046
WM volume (ml)
Absolute (M, SD) 516.5 (57.6) 558.7 (57.6) t= 3.007 0.004
TIV-adjusted (M,
SE)
527.2 (4.44) 542.7 (5.47) F = 4.717 0.033
CSF volume (ml)
Absolute (M, SD) 303.4 (61.4) 332.2 (76.1) t= 1.744 0.086
TIV-adjusted (M,
SE)
312.8 (8.08) 318.1 (9.96) F = 0.165 0.696
p -value in bold for p < 0.05 and in italics for p < 0.1.
Fig. 1. Areas of signiﬁcantly increased grey matter in the CFS group compared to the control group. Results show the FWE-corrected p-value map (1-p, p < 0.05) overlaid on the average
of all normalized images of the entire sample. Numbers indicate y-coordinate of the slice in MNI space.
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volumes in two small patient cohorts, but no diﬀerence in WM volume.
On the contrary, relative GM volume was larger in patients in the
current sample. Even restricting the current analysis to only female
participants, as de Lange and colleagues had done, we continue to ﬁnd a
signiﬁcant reduction in WM, but not GM volume. The trend-level re-
duction in CSF volume and the signiﬁcant reduction in TIV, however,
disappear. Given that the same group recently also failed to replicate
their own ﬁndings of GM reduction (de Lange et al., 2005) in a much
larger sample, which was otherwise highly comparable (van der Schaaf
et al., 2016), the earlier ﬁnding of reduced overall GM volume was
perhaps a chance ﬁnding.
Global WM volume reductions were also reported in a more recent
study, which restricted its analysis to supratentorial WM (Zeineh et al.,
2015). While it is unclear if the current study would still have found
diﬀerences in WM volume if the infratentorial region had been ex-
cluded from the analysis, the fact that the largest areas of regional WM
diﬀerences in the voxel-based analysis were supratentorial suggests that
this would be the case.
Within the patient group, several subjective measures of symptom
severity were related to TIV, with increased symptoms being associated
with smaller TIV. This relationship appeared to be driven by the asso-
ciations with (absolute) GM and CSF volumes. This suggests that CFS
patients with smaller TIV are vulnerable to experiencing more severe
symptoms. Given the weak positive association at statistical trend level
between age at onset and TIV one could speculate that an earlier illness
onset may have caused reduced head growth during adolescence and
also more severe symptoms. However, age at onset was completely
unrelated to any of the symptom measures (all |r| < 0.151, not pre-
viously shown). Given that no previous brain volumetric study in CFS
has reported either group diﬀerences to healthy participants in TIV or
associations of TIV with symptom severity, these ﬁndings in the present
study should be interpreted with caution.
Regional GM volume diﬀerences were found in the right insular
cortex, right temporal gyrus, bilateral amygdala, left medial temporal
lobe and the left lateral occipital lobe and others. However, perhaps
surprisingly, the GM volume in all of these regions was increased in the
Table 2
VBM grey matter results.
Cluster index n Voxel Pseudo-ta x y z Labelb
1 3368 4.93 37.5 −16.5 18.0 R central operculum
4.88 54.0 −1.5 10.5 R central operculum
4.65 27.0 −1.5 −21.0 R amygdala
4.60 40.5 −3.0 −6.0 R posterior insula
4.16 55.5 −12.0 15.0 R central operculum
4.12 66.0 −19.5 −10.5 R middle temporal gyrus
4.12 21.0 10.5 −18.0 R posterior orbital gyrus
4.00 18.0 −3.0 −19.5 R amygdala
3.92 64.5 −22.5 9.0 R cerebral white matter
3.88 16.5 7.5 −10.5 R Putamen
3.83 63.0 −10.5 −22.5 R middle temporal gyrus
3.80 61.5 −19.5 −1.5 R superior temporal gyrus
3.80 49.5 −15.0 10.5 R transverse temporal gyrus
3.77 34.5 0.0 −16.5 R cerebral white matter
3.68 58.5 −7.5 −7.5 R superior temporal gyrus
2.90 21.0 6.0 −3.0 R putamen
2 868 5.69 −4.5 −19.5 7.5 L thalamus proper
4.18 −13.5 −37.5 1.5 L hippocampus
4.15 −10.5 −30.0 4.5 L thalamus proper
3.64 −12.0 −45.0 −4.5 L lingual gyrus
3 741 4.62 −4.5 1.5 −10.5 L cerebral white matter
3.88 −12.0 19.5 −18.0 L medial orbital gyrus
3.50 4.5 −4.5 −1.5 R thalamus proper
3.49 4.5 1.5 −9.0 R ventral diencephalon
3.43 −19.5 10.5 −18.0 L cerebral white matter
3.41 −9.0 31.5 −22.5 L gyrus rectus
3.33 −9.0 42.0 −22.5 L gyrus rectus
3.24 1.5 4.5 −1.5 R cerebral white matter
4 556 5.08 −40.5 22.5 −12.0 L cerebral white matter
4.25 −33.0 27.0 −19.5 L posterior orbital gyrus
4.05 −24.0 30.0 −15.0 L posterior orbital gyrus
5 544 4.57 −27.0 −48.0 −7.5 L lingual gyrus
3.96 −31.5 −34.5 −15.0 L parahippocampal gyrus
3.78 −39.0 −18.0 −22.5 L fusiform gyrus
6 410 5.26 −33.0 −90.0 −4.5 L inferior occipital gyrus
4.62 −25.5 −96.0 1.5 L inferior occipital gyrus
4.48 −42.0 −84.0 −1.5 L inferior occipital gyrus
4.01 −25.5 −94.5 −7.5 L cerebral white matter
7 370 5.59 46.5 10.5 −30.0 R temporal pole
8 258 5.51 −24.0 −1.5 −21.0 L amygdala
9 148 5.26 27.0 −4.5 −45.0 R fusiform gyrus
10 116 3.76 25.5 10.5 −40.5 R temporal pole
11 68 3.86 55.5 3.0 −13.5 R superior temporal gyrus
12 42 4.00 −10.5 −96.0 −13.5 L lingual gyrus
13 31 3.84 −19.5 −69.0 −9.0 L lingual gyrus
14 20 4.32 10.5 28.5 −22.5 R gyrus rectus
15 20 4.37 −31.5 12.0 10.5 L anterior insula
a Reported t-values are the peak values after TFCE-based adjustment.
b Labels according to a maximum probability tissue atlas in CAT12 derived from scans originating from the OASIS project with labelled data provided by Neuromorphometrics, Inc.
(http://neuromorphometrics.com/), L = left, R = right.
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patient group compared to the controls. This stands in contrast to
previous ﬁndings of GM reductions in prefrontal areas (Okada et al.,
2004) and parahippocampal and occipital cortex (Puri et al., 2012).
However, cortical thickness has been shown to be increased in CFS
patients in several right hemisphere regions in one recent study, par-
ticularly for younger individuals (Zeineh et al., 2015). Other studies
failed to show regional GM diﬀerences, although several of these stu-
dies used overall GM segment volume as a covariate in their group
comparison, which may have reduced the power to detect regional
diﬀerences, as systematic diﬀerences between groups in local GM vo-
lume would be partially reﬂected in overall GM volume as well and may
thereby mask regional diﬀerences (Henley et al., 2010).
Of the regional GM diﬀerences that were found in the current study,
the two large areas involving the amygdala with the right one ex-
tending into the insular cortex appear to be of most direct relevance to
CFS symptomatology. The insula is involved in a variety of functions,
including interoceptive (Strigo and Craig, 2016) but also cognitive and
Fig. 2. Areas of signiﬁcantly reduced white matter in the CFS group compared to the control group. Results show the FWE-corrected p-value map (1-p, p < 0.05) overlaid on the average
of all normalized images of the entire sample. Numbers indicate y-coordinate of the slice in MNI space.
Table 3
VBM white matter results.
Cluster
index
n Vox Pseudo-t x y z Labelsa
1 9640 7.96 −12 −1.5 −7.5 L internal capsule
7.07 12 −1.5 −6 R internal capsule
6.88 21 13.5 −15 R inferior fronto-
occipital fasciculus
5.89 9 −19.5 −25.5 R corticospinal tract
5.61 −6 −18 −25.5 L corticospinal tract
5.18 1.5 3 −3 Anterior commissure
4.69 31.5 13.5 −4.5 R external capsule
4.58 −30 12 −4.5 L external capsule
4.39 36 3 31.5 R precentral gyrus
4.24 −21 13.5 −13.5 L inferior fronto-
occipital fasciculus
4.19 31.5 24 −16.5 R lateral fronto-
orbital gyrus
4.07 −24 18 1.5 L external capsule
4.06 −25.5 10.5 −10.5 L inferior fronto-
occipital fasciculus
3.96 −4.5 −30 −19.5 L superior cerebellar
peduncle
3.95 31.5 −12 9 R external capsule
3.77 25.5 −24 0 R stria terminalis
3.76 25.5 −21 −1.5 R cerebral peduncle
3.7 30 −6 22.5 R superior corona
radiata
3.7 25.5 19.5 4.5 R external capsule
3.61 10.5 15 −12 R putamen
3.45 31.5 −3 10.5 R external capsule
3.22 45 4.5 30 R precentral gyrus
3.21 27 10.5 15 R external capsule
3.14 9 25.5 −6 R genu of corpus
callosum
2.99 19.5 34.5 −9 R anterior corona
radiata
2 1116 6.09 33 −3 −13.5 R inferior fronto-
occipital fasciculus
5.75 36 0 −25.5 R middle temporal
gyrus
4.22 45 −6 −39 R inferior temporal
gyrus
3 53 4.73 −1.5 −40.5 −51 Medulla oblongata
a Labels based on the CAT12 provided version of the JHU-MNI-ss atlas (Oishi et al.,
2009), L = left, R = right.
Table 4
Relationship to clinical characteristics.
TIV GM volume WM volume CSF volume
FIS total −0.354
0.023
−0.587
0.011
0.349
0.138
−0.420
0.015
FIS cognitive −0.336
0.032
−0.663
0.004
0.399
0.089
−0.371
0.030
FIS physical −0.174
0.276
−0.304
0.206
0.304
0.226
−0.395
0.031
FIS social −0.400
0.010
−0.598
0.009
0.301
0.139
−0.411
0.016
COMPASS-31 −0.261
0.099
−0.333
0.163
0.230
0.352
−0.395
0.030
CFQ −0.483
0.001
−0.689
0.002
0.340
0.114
−0.500
0.002
Duration of symptoms −0.020
0.901
−0.384
0.096
0.132
0.579
0.242
0.159
Age at onset 0.266
0.089
−0.139
0.545
0.213
0.377
0.301
0.087
Standardized regression coeﬃcients when predicting clinical measures based on segment
volumes in simple regression (TIV) or multiple regression analyses (GM, WM, CSF vo-
lumes). In the case of TIV the coeﬃcient is numerically identical to the Pearson corre-
lation between the two variables.
p -value in bold for p < 0.05 and in italics for p < 0.1.
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aﬀective functions and is directly connected to subcortical targets such
as the amygdala (Shura et al., 2014). The amygdala has also been linked
to a variety of diﬀerent functions, including emotional processing, fear
conditioning and memory processes. Enlarged amygdala volume has
been shown in individuals with joint hypermobility (Eccles et al.,
2012), an abnormality of connective tissue which has been linked to
CFS and similar conditions (Eccles et al., 2015; Nijs et al., 2006).
However, as joint hypermobility was not assessed in the current study
the degree to which it may have played a role the present ﬁndings re-
mains unknown.
Previous models of CFS have hypothesised a role for the amygdala
in the pathophysiology of the condition (Gupta, 2002; Wyller et al.,
2009). Its general role is perhaps best described as a salience and va-
lence detector (Benarroch, 2015). It evaluates whether or not incoming
sensations are of potential consequence for the equilibrium of the or-
ganism (salience) and whether any such disturbances are negative or
positive (valence). The observed GM changes in the amygdala, together
with the changes seen in the insula, could therefore suggest altered
processing and evaluation, particularly of interoceptive signals in pa-
tients with CFS with consequences for both autonomic responses and
cognitive/aﬀective processing. Two recent studies showed reduced
resting-state functional connectivity in CFS patients in the insula
(Boissoneault et al., 2016; Wortinger et al., 2016). Previous ﬁndings of
GM volume reductions in dorsolateral prefrontal cortex (DLPFC) may
further support this notion. The DLPFC and the amygdala are part of a
larger network of brain regions that is involved in the processing of
emotional information and stress (Comte et al., 2016; Sinha et al.,
2016). The observed changes in structure and function in these areas
across diﬀerent studies therefore support the hypothesis that CFS is
associated with alterations to this cortico-limbic system.
The identiﬁed GM diﬀerences in the other areas are more diﬃcult to
interpret given their location and extent. In general, areas around the
superior temporal sulcus are associated with speech and auditory
functions (Alho et al., 2014; Zaehle et al., 2008), though they tend to be
more lateralized to the left side, not the right. However, the GM in-
creases are adjacent to areas of white matter that has been shown to be
abnormal in CFS in our own and in a previous study (Zeineh et al.,
2015). Similarly, it is unclear how the cluster we identiﬁed in the lat-
eral occipital lobe could be relevant for CFS, as it appears to incorporate
cortical areas that are primarily concerned with various aspects of basic
visual processing (Kolster et al., 2010).
The locations of regional white-matter abnormalities that were
identiﬁed in the current study appear to overlap considerably with
regional WM changes seen in other studies. The current study identiﬁed
reduced WM in an area of the anterior temporal lobe, which appears to
belong to the uncinate fasciculus (UF). A recent DTI study (Zeineh et al.,
2015) showed that CSF patients had increased fractional anisotropy
(FA) in the anterior part of the right inferior longitudinal fasciculus
(ILF), which they argued could be due to a reduction in crossing ﬁbres.
Importantly, ILF and UF meet in the anterior portion of the temporal
lobe. The observed WM volume reductions in the UF from the current
study may therefore indirectly support the hypothesis of reduced
crossing ﬁbres as an explanation for the increase in FA in the ILF ob-
served in this earlier study (Zeineh et al., 2015).
Other areas of reduced WM in the current study were those seen in
the midbrain and brainstem. The midbrain cluster shows some resem-
blance to areas identiﬁed by others, who reported WM volume changes
in a large parts of the midbrain (Barnden et al., 2011). However, instead
of a signiﬁcant group diﬀerence the previous study showed a signiﬁcant
negative correlation between WM volume and fatigue duration in pa-
tients. Given this strong correlation, it is surprising that no group dif-
ference was found, if one considers controls as individuals with zero
(chronic) fatigue duration. The two areas also don't seem to fully
overlap, with the one from the present study being located slightly
more anteriorly and more dorsally. Nonetheless, similar WM tracts
appear to be aﬀected in both studies.
It is possible that the area of reduced WM in the ventral pons con-
sists of the same WM tracts that already showed reductions further
ventrally. Barnden and colleagues (Barnden et al., 2011) also identiﬁed
a large cluster involving the brainstem and cerebellum that showed a
diﬀerential association between T1-weighted signal intensity and se-
ated pulse pressure in the CFS compared to the healthy control group.
They hypothesised altered cerebral autoregulation via astrocyte dys-
function as a potential cause for their pattern of results. If impaired
cerebral autoregulation is indeed causing the eﬀects observed by
Barnden and colleagues, this could ultimately result in tissue damage
and volume reductions. The diﬀerences in methodology and the larger
sample size of the current study may account for the fact that the
previous study did not ﬁnd a group diﬀerence in volume, whereas the
current study did.
Several limitations of the current study need to be acknowledged.
First, although one of the largest studies to date that investigates brain
morphometric diﬀerences in CFS, the sample size of the present study
can still only be considered moderate. This is particularly important
given the heterogeneity of symptom presentation and illness progres-
sion in CFS. Larger samples, perhaps from collaborative studies, will be
necessary to further elucidate the role of altered brain structure and
function in CFS. Ideally such studies should consider longitudinal de-
signs, as the currently available studies, which are almost exclusively
cross-sectional, will be unable to distinguish potential causes from
consequences of CFS. Second, in the current study no diﬀusion
weighted images were available to further elucidate the apparent vo-
lumetric changes in WM. Thus, it is unclear if the volumetric diﬀerences
seen in the current study correspond to changes in WM microstructure.
Multimodal imaging approaches such as those presented by others
(Barnden et al., 2011; Barnden et al., 2016; Zeineh et al., 2015) should
be performed whenever possible to more comprehensively characterise
any changes to brain structure in CFS. Lastly, it should be noted that, at
the time of writing, the CAT12 toolbox (Gaser and Dahnke, 2016),
which was used for segmentation and normalization, had not yet been
formally evaluated.
5. Conclusion
The current study showed alterations in both grey matter and white
matter volume in patients with Chronic Fatigue Syndrome. Some of
those ﬁndings, particularly those in GM, are novel and may indicate
altered processing of interoceptive signals in CFS patients. Future stu-
dies should incorporate measures of interoceptive processing to more
directly interrogate this potential link to CFS. The diﬀerences in WM
volume were seen in areas that have previously shown abnormalities in
CFS albeit partially of a diﬀerent kind. The current ﬁndings suggest
abnormalities in a network of insular-limbic regions, as well as changes
to WM tracts of the midbrain, brainstem and temporal cortex.
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